Top Markets
Coin of the day
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Classement en actions #14209
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Prix de l'action
$12.33
Capitalisation boursière
$428.31M
Changement (1 jour)
0.49%
Changement (1 an)
39.01%
Pays
US
Échange Fennec Pharmaceuticals Inc. (FENC)

Catégorie

Historique du prix de l'action pour Fennec Pharmaceuticals Inc. (FENC)
Prix de clôture le plus élevé : $11.76 le 2026-08-01

Prix de clôture le plus bas : $11.52 le 2017-09-01
Historique du prix de l'action de Fennec Pharmaceuticals Inc. de 2017 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 11.99%
2025 25.75%
2024 -39.44%
2023 2.87%
2022 131.45%
2021 -44.21%
2020 23.34%
2019 -0.18%
2018 -33.41%
2017 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$544.38 39.22%
US
$1.03K 45.21%
NL
$122.88 -10.84%
AU
$138.80 476.17%
US
$749.90 5.10%
CH